Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, and Immune Cell Function and Interaction.
CAR-engineered lymphocyte persistence is governed by a FAS ligand–FAS autoregulatory circuit
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
A perception-based nanosensor platform to detect cancer biomarkers
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function